首页|粉防己碱上调PTEN表达逆转肝细胞癌细胞顺铂耐药的研究

粉防己碱上调PTEN表达逆转肝细胞癌细胞顺铂耐药的研究

扫码查看
目的 探究粉防己碱上调人第10号染色体缺失的磷酸酶(PTEN)表达对逆转肝细胞癌细胞顺铂耐药的作用.方法 将Huh7/DDP细胞分为空白对照组、NC组、a组、b组.空白对照组不接受任何处理,仅用正常培养基培养;NC组在正常培养基中加入16 μmol·L-1顺铂;a组在正常培养基中加入16 μmol·L-1顺铂,添加5 μmol·L-1粉防己碱;b组在正常培养基中加入16 μmol·L-1顺铂,并添加5 μmol·L-1粉防己碱,同时过表达PTEN.用细胞计数试剂盒-8(CCK-8)法评估细胞存活率,用免疫荧光法检测PTEN基因的表达情况,以及多药耐药相关蛋白(MRP)-3和MRP-5的表达情况.结果 空白对照组、NC组、a组和b组的细胞存活率分别为(98.74±9.26)%、(55.08±6.38)%、(35.17±4.87)%和(24.06±4.16)%,PTEN 表达水平分别为 1.00±0.13、1.03±0.13、1.58±0.17 和 2.18±0.24,MRP-3 蛋白表达水平分别为1.00±0.08、1.03±0.14、0.71±0.07 和0.48±0.04,MRP-5 蛋白表达水平分别为 1.00±0.11、0.97±0.12、0.63±0.07 和 0.40±0.05.空白对照组的上述指标与NC组比较,a组的上述指标与b组比较,在统计学上差异均有统计学意义(均P<0.05).结论 粉防己碱通过上调PTEN表达来逆转肝细胞癌细胞顺铂耐药的作用,并发现其能抑制耐药相关蛋白MRP-3和MRP-5的表达.
Study of tetrandrine upregulating PTEN expression to reverse cisplatin resistance in hepatocellular carcinoma cells
Objective To investigate the effect of tetrandrine on reversing cisplatin resistance in hepatocellular carcinoma cells by up-regulating phosphatase and tensin homolog deleted on chromosome ten(PTEN)expression.Methods Huh7/DDP cells were divided into control group,NC group,group a and group b.The control group received no treatment and was cultured with normal medium only.In NC group,16 μmol·L-1 cisplatin was added into normal medium.In group a,16 μmol·L-1 cisplatin and 5 μmol·L-1 tetrandrine were added into normal medium.In group b,16 μmol·L-1 cisplatin and 5 μmol·L-1 tetrandrine were added to normal medium,and PTEN was overexpressed.Cell survival was assessed by cell counting kit-8(CCK-8)method,and PTEN gene expression was detected by immunofluorescence.The impact on multidrug resistance associated protein(MRP)-3 and MRP-5 were observed.Results The cell survival rates of control group,NC group,a group and b group were(98.74±9.26)%,(55.08±6.38)%,(35.17±4.87)%and(24.06±4.16)%;the expression of PTEN gene were 1.00±0.13,1.03±0.13,1.58±0.17 and 2.18±0.24;the expression of MRP-3 protein were 1.00±0.08,1.03±0.14,0.71±0.07 and 0.48±0.04;MRP-5 protein expression were 1.00±0.11,0.97±0.12,0.63±0.07 and 0.40±0.05,respectively.Compared between NC group and control group,compared between group a and group b,there were statistically significant differences in the above indexes(all P<0.05).Conclusion Tetrandrine reverses cisplatin resistance in hepatocellular carcinoma cells by up-regulating PTEN expression and inhibits the expression of drug resistance-related proteins MRP-3 and MRP-5.

tetrandrinehepatocellular carcinomacisplatin resistancephosphate and tension homology deleted on chromosome ten gene

蒋飞、秦依雯

展开 >

常州市妇幼保健院药事科,江苏常州 213000

粉防己碱 肝细胞癌 顺铂耐药性 人第10号染色体缺失的磷酸酶

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(11)
  • 15